BREAST CANCER STAGE III
Clinical trials for BREAST CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER STAGE III trials appear
Sign up with your email to follow new studies for BREAST CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation battle: protons vs. photons to protect hearts in breast cancer
Disease control OngoingThis study aims to see if proton beam radiation causes less heart damage than traditional photon radiation for people with left-sided breast cancer. Researchers will randomly assign 60 participants to receive either proton or photon radiation and use heart MRI scans to measure sc…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cancer drug enters first human trials for multiple tumor types
Disease control OngoingThis is the first human study testing the safety and early effects of an experimental drug called BL-M17D1 in people with advanced cancers that have a specific marker called HER2. The trial will enroll 120 adults with various hard-to-treat cancers, including breast, lung, and sto…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Can exercise after breast cancer treatment keep cancer from coming back?
Disease control OngoingThis study is testing whether a 16-week exercise program can reduce harmful inflammation in body fat for overweight breast cancer survivors who have finished treatment. Researchers want to see if lowering this inflammation might help decrease the risk of the cancer returning. The…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New study tests if advanced proton radiation is gentler on the heart and lungs
Disease control OngoingThis study aims to see if proton beam radiation causes fewer side effects to the heart, lungs, and other nearby organs compared to standard radiation for people with stage II or III breast cancer. It follows 100 patients who are already part of a larger trial comparing the two ra…
Matched conditions: BREAST CANCER STAGE III
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New hope for nigerian women with aggressive breast cancer
Disease control OngoingThis study is testing how well a combination of two drugs (docetaxel and trastuzumab) works to shrink tumors before surgery in Nigerian women with a specific type of breast cancer called HER2-positive. The main goal is to see if the treatment can completely eliminate the cancer c…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New surgical method could spare breast cancer patients from debilitating arm swelling
Disease control OngoingThis large Phase 3 trial is testing whether a surgical technique called axillary reverse mapping can prevent lymphedema—painful arm swelling—in breast cancer patients having lymph node removal surgery. Researchers are comparing patients who receive the new mapping procedure durin…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Vaccine trial aims to stop aggressive breast Cancer's return
Prevention OngoingThis study is testing two different vaccines designed to prevent breast cancer from returning in patients with HER2-positive disease. It focuses on people who still had cancer cells remaining after completing their initial chemotherapy and targeted therapy. Researchers will monit…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC
-
New approach aims to ease depression for black breast cancer survivors
Symptom relief OngoingThis study is developing and testing a shorter version of mindfulness therapy specifically for older Black women who have survived breast cancer and are experiencing mild to moderate depression. The program involves 8 weekly one-hour online group sessions that combine mindfulness…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 24, 2026 12:03 UTC
-
Cooling cap trial aims to save hair for black women in chemo
Symptom relief OngoingThis study is testing whether a special cooling cap can help prevent hair loss in Black patients receiving chemotherapy for breast cancer. It involves 30 participants who will use the cap during their treatment. The main goal is to see if the cap helps patients keep at least half…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: George Washington University • Aim: Symptom relief
Last updated Mar 18, 2026 14:55 UTC
-
Can a simple exercise test predict heart health during cancer treatment?
Knowledge-focused OngoingThis study aims to understand how much oxygen women with HER2-positive breast cancer use during exercise when they have mild heart issues from their cancer treatment. Researchers want to see if this exercise test can predict how well participants' hearts and lungs will work if th…
Matched conditions: BREAST CANCER STAGE III
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
New tool aims to give breast cancer patients more say in their surgery
Knowledge-focused OngoingThis study is testing a special guide, called a decision aid, designed to help people newly diagnosed with early-stage breast cancer be more involved in choosing between surgery options like lumpectomy or mastectomy. It involves over 600 patients across 10 clinics and focuses on …
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:26 UTC